EXEL

EXELIXIS INC

EXEL·30161Q104·US·Common Stock·Healthcare - Biotechnology-Activist

EXEL (EXELIXIS INC) is held by 244 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1.6B), FARALLON CAPITAL MANAGEMENT, L.L.C. ($732.8M), RENAISSANCE TECHNOLOGIES LLC ($730.6M). Net institutional sentiment: Mixed.

244
Holders
(21 Elite)
$12.2B
Total Value
44% (237)
Consensus
105 buying - 132 selling
13F: Insider & Congress: Updated regularly
EXEL

Smart Money Verdict

View all
Loading verdict
Held by 244 funds
21 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders May 8, 2026 · Activists Aug 14, 2026 · Congress none

ActivistFarallon Capital Management, L.L.C.Farallon Capital Management, L.L.C.5.6%Aug 14, 2026
ActivistAQR Capital Management, LLCAQR Capital Management, LLC4.4%Aug 12, 2026
InsiderFCFreire Maria CSell $949KMay 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
29.1M(-5.7%)$1.6B0.0%+59.56%
0
Increased
13.5M(+2.7%)$732.8M3.4%+128.87%
60
Decreased
13.4M(-2.2%)$730.6M1.0%+166.56%
0
Decreased
12M(-0.3%)$655.3M0.0%+33.65%
0
Decreased
11M(-15.8%)$598.6M0.2%+50.88%
0
Decreased
11M(-2.7%)$595.8M0.0%+33.65%
0
Decreased
10M(-3.2%)$542.5M0.0%+123.19%
0
Increased
8.9M(+4.5%)$485.8M1.3%+50.50%
52
Decreased
7.7M(-1.9%)$416.3M0.0%+113.77%
0
Increased
5.6M(+54.1%)$302.1M0.1%+18.62%
52
Increased
4.5M(+8.2%)$245.9M0.0%+54.17%
33
Increased
4.5M(+4.2%)$244.6M0.0%+61.56%
32
Increased
4.4M(+3.0%)$240.9M0.0%+135.93%
32
Decreased
4.4M(-9.7%)$237.6M0.1%+59.89%
0
Increased
4.2M(+90.8%)$229.1M0.2%+15.09%
58
Increased
3.4M(+1.3%)$186.8M0.3%+33.82%
37
Decreased
3.3M(-13.4%)$178.3M0.0%+40.81%
0
Increased
3.2M(+32.4%)$172.4M0.0%+28.95%
39
Increased
2.7M(+27.0%)$146.4M0.0%+24.44%
38
Increased
2.5M(+0.3%)$138.4M0.1%+83.71%
30

Showing 1-20 of 260

1 / 13
EXELEXELEXELIXIS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used